Founded in 2021 and based in New York, Tourmaline Bio is focused on developing medicines that have the potential to establish new standards-of-care in areas of high unmet medical need. With a team of nimble, driven, and accomplished entrepreneurs, physicians, and industry experts, the company aims to thoughtfully develop transformative medicines that dramatically improve the lives of patients. Their goal is to prevent and treat immune diseases, providing healthcare services that address critical medical challenges.